The Invesco S&P MidCap Momentum ETF (XMMO) offers superior mid-cap exposure by focusing on momentum stocks, outperforming traditional mid-cap ETFs like IJH and MDY over five years. Its strategy captures growth in sectors like industrials and technology, benefiting from trends such as AI infrastructure expansion and commodity exposure. However, XMMO requires pairing with large-cap funds for balance due to its higher valuation (forward P/E of 21.04x versus S&P 400's 16.35x) and risks from its backward-looking momentum strategy, which can lead to losses during market reversals. It is best used as a growth sleeve rather than a core holding in a portfolio.
Elizabeth Crain, a director at Core Scientific, has purchased 6,000 shares of the company. This insider buying may indicate her confidence in the company's future prospects. Such moves often attract investor attention as they can signal positive expe...
Hyperscale Data has stopped Bitcoin mining to focus on AI data center services, backed by a $1.2 billion contract at its Michigan facility. The company's assets, including cash and Bitcoin, are worth nearly double its market cap, suggesting undervalu...
Casey's General Stores reported strong Q1 2026 results, surpassing analyst expectations with an EPS of $7.37 versus $6.78 estimated and revenue of $5.68 billion beating the $5.56 billion forecast. Net income rose 27.1% year-over-year to $273.7 millio...
Academy Sports and Outdoors will announce its Q2 2026 earnings on September 9, with revenue expected to rise 3.8% year-over-year to about $1.66 billion. Analysts forecast earnings per share between $2.07 and $2.12, up from $1.94 last year, indicating...
Pharvaris's experimental oral drug deucrictibant showed an 83% reduction in hereditary angioedema (HAE) attacks in a Phase 3 trial, prompting Oppenheimer to raise its price target from $50 to $75 and maintain an "Outperform" rating. The positive tria...
